haematology
Bleeding disorders

Ticagrelor safe after fibrinolysis – and now there’s a reversal agent


Ticagrelor represents a safe treatment option after fibrinolysis for ST-elevation myocardial infarction (STEMI), with 12-month results from the TREAT study showing it was noninferior to clopidogrel. The primary endpoint (major bleeding at 30 days) was previously reported in 2018 showing comparable...

Ticagrelor represents a safe treatment option after fibrinolysis for ST-elevation myocardial infarction (STEMI), with 12-month results from the TREAT study...

Read more